Breast carcinogenesis as an organising principle for diagnosis and precision therapy
Histopathology · 16.11.2026
DOI: 10.1111/his.70318 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Histopathology, online erschienen am 16.11.2026. Verfasst von Emad Rakha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK. Die Arbeit nennt 89 Literaturangaben.
Abstract (Originalsprache)
Breast cancer (BC) is a biologically heterogeneous disease that evolves through complex interactions between genetic, epigenetic, hormonal and microenvironmental factors. For pathologists, understanding breast carcinogenesis is fundamental to interpreting the morphological and molecular features that underpin tumour classification, prognostic assessment, biomarker evaluation and therapeutic stratification. Rather than a linear process, breast carcinogenesis follows branching evolutionary pathways driven by successive molecular alterations, clonal selection and tumour–microenvironment interactions, resulting in the diverse histological phenotypes encountered in routine practice. These biological processes are reflected morphologically in the spectrum of precursor lesions, in situ neoplasia and invasive carcinomas, while key molecular drivers, including oestrogen receptor signalling, HER2 amplification, PI3K/AKT/mTOR activation, TP53 dysfunction and homologous recombination deficiency, determine tumour behaviour and therapeutic vulnerabilities. Understanding these pathways also provides the biological rationale for contemporary targeted therapies, including endocrine treatment, HER2‐directed agents, PARP inhibitors and other precision therapies. This narrative review integrates current knowledge of breast carcinogenesis with diagnostic pathology, illustrating how tumour evolution shapes morphology, molecular phenotype and clinical behaviour. We propose that carcinogenesis should complement morphology as an organising framework for breast tumour classification, enabling pathologists to interpret histological features within their biological context and strengthening diagnostic accuracy, biomarker interpretation and precision medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
- Pathology Department, National Reference Laboratory, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
- Barts Cancer Institute, Queen Mary University of London, London, UK.
- Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- MORF, Institute de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
ORCID-Profile: Emad Rakha, Basel Altrabulsi, Kas Sidlauskas, Louise J Jones, Mieke van R Bockstal
Zitieren
APA
Rakha, E., Altrabulsi, B., Sidlauskas, K., Jones, L. J., & Bockstal, M. V. R. (2026). Breast carcinogenesis as an organising principle for diagnosis and precision therapy. Histopathology. https://doi.org/10.1111/his.70318
Vancouver
Rakha E, Altrabulsi B, Sidlauskas K, Jones LJ, Bockstal MVR. Breast carcinogenesis as an organising principle for diagnosis and precision therapy. Histopathology. 2026. doi:10.1111/his.70318
BibTeX
@article{Rakha2026,
author = {Rakha, Emad and Altrabulsi, Basel and Sidlauskas, Kas and Jones, Louise J and Bockstal, Mieke van R},
title = {Breast carcinogenesis as an organising principle for diagnosis and precision therapy},
journal = {Histopathology},
year = {2026},
doi = {10.1111/his.70318}
}
EUVIMED